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HCN1 channel subunits, which contribute to the
hyperpolarization-activated cation current (Ih), are
selectively targeted to distal apical dendrites of
hippocampal CA1 pyramidal neurons. Here, we
addressed the importance of the brain-specific
auxiliary subunit of HCN1, TRIP8b, in regulating
HCN1 expression and localization. More than ten
N-terminal splice variants of TRIP8b exist in brain
and exert distinct effects on HCN1 trafficking when
overexpressed. We found that isoform-wide disrup-
tion of the TRIP8b/HCN1 interaction caused HCN1
to be mistargeted throughout CA1 somatodendritic
compartments. In contrast, HCN1 was targeted nor-
mally to CA1 distal dendrites in a TRIP8b knockout
mouse that selectively lacked exons 1b and 2. Of
the two remaining hippocampal TRIP8b isoforms,
TRIP8b(1a-4) promoted HCN1 surface expression in
dendrites, whereas TRIP8b(1a) suppressed HCN1
misexpression in axons. Thus, proper subcellular
localization of HCN1 depends on its differential addi-
tive and subtractive sculpting by two isoforms of
a single auxiliary subunit.
INTRODUCTION
Ion channels are often targeted to select regions of a neuron
where they locally regulate specific physiological functions.
HCN1 channels, which generate the hyperpolarization-activated
cation current, Ih, are expressed in the apical dendrites of hippo-
campal CA1 pyramidal neurons in a striking gradient of in-
creasing density with increasing distance from the soma
(Lorincz et al., 2002; Magee, 1998; Notomi and Shigemoto,
2004; Santoro et al., 1997). As a consequence, Ih acts as a rela-
tively selective inhibitory constraint of the direct cortical perfo-
rant path (PP) inputs to CA1 neurons, which terminate on CA1
distal dendrites in stratum lacunosum moleculare (SLM) (Nolan
et al., 2004; Tsay et al., 2007). In contrast, HCN1 has less effectat Schaffer collateral (SC) synapses, which arise from hippo-
campal CA3 neurons and terminate on more proximal CA1
dendrites in stratum radiatum (SR). Thus, trafficking of HCN1 to
distal dendrites selectively constrains the cortical versus hippo-
campal inputs to CA1 neurons, which may contribute to the
effect of HCN1 to constrain spatial learning and memory (Nolan
et al., 2004).
Despite the importance of the subcellular targeting of HCN1,
the molecular mechanisms underlying this regulatory control
remain unknown. One promising candidate is the auxiliary
subunit of HCN channels TRIP8b (Santoro et al., 2004). This
brain-specific cytoplasmic protein binds to all HCN channels
(HCN1-4) and regulates HCN gating in both heterologous
expression systems and hippocampal cultures (Lewis et al.,
2009; Santoro et al., 2009; Zolles et al., 2009). TRIP8b undergoes
extensive alternative splicing at its N terminus, with more than
ten isoforms expressed in brain. There are two alternate transla-
tion start sites (exons 1a or 1b) followed by variable combina-
tions of exons 2, 3, and 4. The majority of the protein, encoded
by exons 5–16, is constant among isoforms. The various TRIP8b
isoforms exert dramatically different effects to upregulate or
downregulate HCN1 surface expression when overexpressed
heterologously or in dissociated neurons.
Based on real-time PCR and western blot analysis of brain
tissue, TRIP8b(1a-4), and TRIP8b(1a) represent the two most
prominently expressed isoforms, with TRIP8b(1b-2) expressed
at somewhat lower levels (Lewis et al., 2009; Santoro et al.,
2004, 2009). TRIP8b(1b-2) overexpression causes a near
complete loss of HCN1 surface expression and Ih, in both
heterologous cells and hippocampal neurons (Lewis et al.,
2009; Santoro et al., 2004, 2009). This effect is likely caused by
clathrin-mediated channel endocytosis through the binding of
adaptor protein (AP) complexes to specific tyrosine-based and
dileucine trafficking motifs in the TRIP8b N terminus (Santoro
et al., 2004, 2009). In contrast, TRIP8b(1a-4) enhances surface
expression of HCN1 (Lewis et al., 2009; Santoro et al., 2009).
The effect of TRIP8b(1a) depends on cellular context, causing
a 10-fold decrease in HCN1 surface expression in oocytes
(Santoro et al., 2009, 2011) while enhancing HCN1 expression
in HEK293 cells (Lewis et al., 2009).
Although exogenously expressed TRIP8b is a potent regu-
lator of HCN1 in vitro and in vivo, little is known about howNeuron 70, 495–509, May 12, 2011 ª2011 Elsevier Inc. 495
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Targeting of HCN1 Channels by TRIP8b Isoformsendogenous TRIP8b controls HCN1 trafficking in the brain.
Using immunohistochemical, electrophysiological, and genetic
targeting approaches, we found that endogenous TRIP8b is
a necessary element for the trafficking of HCN1 to the surface
membrane of CA1 pyramidal cells in vivo. Moreover, we found
that TRIP8b(1a-4), which upregulates HCN1 in heterologous
systems, is the key isoform involved in dendritic expression of
HCN1. In contrast, TRIP8b(1a), which causes downregulation
of HCN1 surface expression in Xenopus oocytes, is important
for preventing mislocalization of HCN1 in the axons of CA1
pyramidal neurons. Furthermore, we provide evidence that
TRIP8b isoforms containing exon 1b are largely expressed in
oligodendrocytes, where they are coexpressed with HCN2
(Notomi and Shigemoto, 2004). Thus, the variety of TRIP8b
N-terminal splice isoforms is important for differential regulation
of HCN channels in distinct neuronal compartments and distinct
cell types.
RESULTS
TRIP8b Knockdown Reduces Ih in CA1 Pyramidal
Neurons Both In Vitro and In Vivo
To investigate the role of TRIP8b in the regulation of HCN1 chan-
nels in vivo, we reduced endogenous levels of all isoforms using
short interfering RNA (siRNA) designed against a constant region
of TRIP8b. A lentivirus vector delivered either the TRIP8b-
specific siRNA or a scrambled control siRNA. The same vector
also independently expressed enhanced green fluorescent
protein (EGFP) to mark infected neurons. We confirmed the
efficacy and specificity of our chosen siRNA sequence in disso-
ciated hippocampal neuron cultures (Figures 1A–1D). TRIP8b
siRNA reduced the amount of TRIP8b protein in western blots
relative to control siRNA. Furthermore, the amplitude of Ih in
whole-cell voltage-clamp recordings was significantly smaller
in neurons expressing TRIP8b siRNA versus neurons expressing
control siRNA. Thus, Ih density (see Supplemental Experimental
Procedures available online) was reduced from 1.40 ± 0.2 pA/pF
(mean ± SEM, N = 21 cells) in neurons infected with control
siRNA to 0.35 ± 0.05 pA/pF (N = 23 cells) in neurons infected
with TRIP8b siRNA (p < 0.01, t test). These results confirm those
of Lewis et al. (2009), who used a different siRNA sequence to
knockdown TRIP8b in vitro. In independent experiments, we
verified that both TRIP8b siRNAs exerted similar effects to
reduce Ih amplitude (R.P, and S.A.S., unpublished data)..
When we measured whole cell currents in the presence of the
Ih antagonist ZD7288 (10 mM), there was no difference in current
amplitude from cells expressing TRIP8b siRNA versus control
siRNA (Figure 1B; current density was 0.22 ± 0.03 pA/pF with
control siRNA and 0.18 ± 0.02 pA/pF with TRIP8b siRNA;
p > 0.5, t test). This provides strong evidence that the action of
TRIP8b siRNA is specific for Ih with no obvious off-target effects.
As HCN1 is not properly targeted to distal dendrites of hippo-
campal neurons in dissociated cell cultures, we examined the
effect of reducing TRIP8b levels on Ih expression in CA1 pyra-
midal neurons in vivo. Lentivirus encoding TRIP8b siRNA or
control siRNA was injected under stereotactic control into the
CA1 region of the hippocampus of 5-week-old mice. After
2 weeks, brains were dissected and sliced for immunohisto-496 Neuron 70, 495–509, May 12, 2011 ª2011 Elsevier Inc.chemical analysis. The EGFP-positive (infected) regions of CA1
from hippocampi expressing TRIP8b siRNA had reduced levels
of TRIP8b staining compared with neighboring regions of CA1
that were not EGFP-positive (Figure S1). No change in TRIP8b
staining was detected in slices infected with virus expressing
control siRNA, confirming the in vivo efficacy and specificity of
the siRNA.
To examine the effect of in vivo knockdown of TRIP8b on HCN
channel surface density, we obtained whole-cell recordings from
EGFP-positive CA1 pyramidal neurons in acute slices from
hippocampi injected with virus expressing either TRIP8b siRNA
or control siRNA. Because of limitations in achieving adequate
voltage-clamp of CA1 dendrites in acute slices, we relied on
current clamp measurements of electrophysiological parame-
ters known to reflect Ih (Magee, 1998, 1999) and HCN1 (Nolan
et al., 2004). We found that CA1 neurons infected with TRIP8b
siRNA displayed a series of changes consistent with a marked
reduction in Ih. First, there was a 3 mV negative shift in the
resting potential of neurons infected with TRIP8b siRNA
(72.1 ± 1.0 mV; n = 15) compared with control siRNA
(69.0 ± 0.9 mV; n = 18; p < 0.05, t test), consistent with a loss
of the depolarizing influence of Ih. Moreover, this difference
was eliminated in the presence of ZD7288 (TRIP8b siRNA:
78.7 ± 0.9 mV; n = 15; control siRNA: 78.4 ± 0.7 mV;
n = 18), indicating a specific role of Ih (Figure 1B). Second,
knockdown of TRIP8b caused a large increase in input resis-
tance (TRIP8b siRNA: 140.5 ± 9.9 MU; n = 15; control siRNA:
89.67 ± 5.1 MU; n = 18; p < 0.01, t test), consistent with the
loss of HCN channels (Figure 1F). This effect was also abolished
by ZD7288 (TRIP8b siRNA: 189.9 ± 11.4 MU; n = 15; control:
180.1 ± 10.5 MU; n = 18). Third, the depolarizing sag in response
to a hyperpolarizing current step, characteristic of Ih activation,
was significantly decreased in CA1 neurons infected with
TRIP8b siRNA (TRIP8b siRNA: sag ratio = 0.10 ± 0.02; n = 15;
control: sag ratio = 0.24 ± 0.02; n = 18; p < 0.01, t test) (Figure 1G).
In neurons expressing TRIP8b or control siRNA, the sag was
eliminated by 10 mM ZD7288.
Next, we examined changes in Ih based on the decay time
course of the PP EPSP, which is sped up by HCN channels in
distal dendrites (Magee, 1999; Nolan et al., 2004). Knockdown
of TRIP8b led to a 70% increase in the t1/2 (time to decay by
50%) of PP EPSPs relative to control (TRIP8b siRNA: 28.36 ±
1.26 ms, n = 15; control siRNA: 47.79 ± 2.92 ms, n = 18;
p<0.01; Figure 1H). Addition of ZD7288 increased the t1/2 further,
and to identical values in both populations of neurons (TRIP8b
siRNA: 62.91 ± 1.47 ms; n = 15; control: 63.45 ± 2.14 ms;
n= 18). These results are consistentwith the view that a reduction
of TRIP8b protein in CA1 pyramidal neurons in vivo causes
a substantial and specific decrease in somatodendritic Ih.
Reduction of TRIP8b Disrupts HCN1 Protein Trafficking
in CA1 Pyramidal Neurons
To examine how reduction in TRIP8b causes loss of Ih, we used
immunohistochemistry to examine the expression and localiza-
tion of HCN1 protein (the predominant HCN isoform in pyramidal
neurons) following siRNA-mediated knockdown of TRIP8b.
Viral expression of TRIP8b siRNA, but not control siRNA,
caused a marked redistribution of HCN1 in CA1 neurons, with
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Figure 1. Expression of TRIP8b siRNA Alters the Electrophysiological Properties of CA1 Neurons Consistent with a Reduction in Ih In Vitro
and In Vivo
(A) Western blot of total protein extracts from hippocampal neuron cultures 18 days in vitro infected with lentiviral vectors expressing EGFP plus either control
siRNA or TRIP8b siRNA. Note that TRIP8b siRNA reduced TRIP8b levels with no change in tubulin from cultures expressing roughly equal amounts of EGFP. The
long arrow points to the TRIP8b(1a-4) band and the short arrow to TRIP8b(1a).
(B) Voltage clamp recordings from dissociated hippocampal cultures show reduction in Ih with TRIP8b siRNA compared with control siRNA, before and after
application of 10 mM ZD7288. Currents elicited by 3 s hyperpolarizing voltage steps from holding potential of –40 mV to –130 mV in 10 mV increments.
(C) Current clamp recordings from dissociated hippocampal cultures show voltage responses to a 80 pA hyperpolarizing current step before and after
application of 10 mM ZD7288.
(D) Mean Ih current density from cells expressing control or TRIP8b siRNAs, before and after application of 10 mM ZD7288 (mean ± SEM).
(E–H) Electrophysiological properties of CA1 pyramidal neurons in acute slices expressing either control or TRIP8b siRNAs. Lines connect individual data points
(small circles) from same slice in absence or presence of 10 mM ZD7288. Large circles: mean ± SEM.
(E) Resting membrane potential.
(F) Input resistance (measured with a 500 ms 50 pA hyperpolarizing current step).
(G) Sag ratio (see Experimental Procedures). Traces show voltage responses to hyperpolarizing current pulses from a holding potential of 70 mV in absence
(black traces) or presence (red traces) of 10 mM ZD7288 from cells expressing control (left) or TRIP8b (right) siRNA.
(H) Somatic EPSP decay time (t1/2). Traces show somatic EPSPs in response to PP stimulus from cells expressing control (left) or TRIP8b (right) siRNAs, either in
absence (black traces) or presence (red traces) of 10 mM ZD7288.
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Targeting of HCN1 Channels by TRIP8b Isoformsa significant increase in channel staining in the somatic layer and
proximal dendrites in SR, compared with uninfected neurons in
the same slice (Figure 2A). High magnification z-series sections
revealed the appearance of HCN1 in discrete puncta in the cyto-
plasm surrounding the nucleus of neurons expressing the
TRIP8b siRNA (Figure 2B). Such puncta were not observed in
neighboring uninfected cells or in neurons infected with control
siRNA.
These results were quantified by measuring the intensity of
HCN1 staining in the pyramidal layer (SP), proximal dendrites
(SR) and distal dendrites (SLM) of infected (EGFP +) and unin-
fected (EGFP -) CA1 neurons (Figure 2C). There was no signifi-
cant difference in HCN1 staining between uninfected cells and
cells infected with control siRNA. However, cells infected withTRIP8b siRNA exhibited a 43% increase in HCN1 staining inten-
sity in the soma and a 22% increase in the SR, compared with
uninfected neighboring cells in the same slice (N = 6 mice, 12
injections sites for TRIP8b siRNA, N = 4 mice, 8 injections sites
for control. Each data point is the average of 17 regions). In
contrast, there was no detectable difference in staining intensity
in SLM between regions infected with TRIP8b siRNA versus
uninfected regions.
The punctate pattern of HCN1 suggests that the increase in
staining in the soma and proximal dendrites results from channel
accumulation in an intracellular compartment, consistent with
the observed decrease in Ih (see Figures 1D–1H). These results
imply that a reduction in TRIP8b expression produces a defect
in HCN1 membrane trafficking. The lack of change in HCN1 inNeuron 70, 495–509, May 12, 2011 ª2011 Elsevier Inc. 497
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Figure 2. In Vivo siRNA-Mediated Knockdown of TRIP8b Reduces Its Protein Levels and Leads to Redistribution of HCN1
(A) Expression pattern of EGFP, HCN1 or TRIP8b in CA1 region of hippocampal slices from brains of mice in which lentiviral vectors expressing control siRNA (top
row) or TRIP8b knockdown siRNA (bottom row) were injected stereotactically in CA1. Left column, Images of EGFP fluorescence reveal variable pattern of viral
expression, which ranged across transverse axis of a hippocampal slice from regions with very high siRNA expression (thick solid arrow), to regions with
intermediate expression (thin arrow), to regions with undetectable viral infection (open arrow).Right column, Levels of TRIP8b detected by immunohistochemistry
were decreased in region of slice where viral expression (EGFP signal) was highest (thick solid arrow). Levels of TRIP8b were unaffected in region of slice where
viral expression was undetectable (open arrow). Middle column, Levels of HCN1 increased in somatic layer of CA1 where viral expression was very high (thick
solid arrow). The scale bar represents 300 mm.
(B) Higher-magnification z-series projections showing specific redistribution of HCN1 protein into the somatic layer of CA1 pyramidal cells infected with TRIP8b
knockdown siRNA. Note lack of somatic staining with control siRNA. The scale bar represents 10 mm.
(C) Quantification of HCN1 staining in the SP, SR and SLM regions of CA1 infected with control (top) or anti-TRIP8b (bottom) siRNAs. EGFP-positive regions were
compared with EGFP- negative regions in same slice. HCN1 fluorescence intensity was normalized by setting the maximal intensity of the image to 1. Note
significant increase in relative staining in soma and SR of slices expressing TRIP8b siRNA (*p < 0.05; t test).
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Targeting of HCN1 Channels by TRIP8b IsoformsSLM may reflect technical limitations of the immunohistochem-
ical approach to detect a redistribution of HCN1 from the
membrane to cytoplasmic compartments in the thin distal
dendrites. In addition, high levels of background HCN1 staining
in lateral dendritic branches from uninfected neurons may498 Neuron 70, 495–509, May 12, 2011 ª2011 Elsevier Inc.prevent the detection of changes in channel expression in those
neurons infected with virus. Finally, the interaction of TRIP8b
with HCN1 in distal dendrites may be extremely stable and
persist even when the pool of available TRIP8b is decreased
(Santoro et al., 2009).
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Figure 3. TRIP8b siRNA Impairs the Dendritic Expression of EGFP-
HCN1 in HCN1 KO Mice
(A) EGFP-HCN1 was coexpressed with either control (top row) or TRIP8b
(bottom row) siRNAs using independent lentiviral vectors in HCN1 KO mice.
Left column: Fluorescence signal from EGFP-HCN1. Middle column: DsRed2
signal (expressed from siRNA vector). Right column: merged signal showing
EGFP-HCN1 (green) and DsRed2 (red). Note effect of TRIP8b siRNA to reduce
EGFP-HCN1 signal, especially in distal dendrites. The scale bar represents
100 mm.
(B) Ratio of EGFP-HCN1 to DsRed2 fluorescence as function of distance along
somatodendritic axis in slices infected with control (filled symbols) or TRIP8b
(open symbols) siRNAs. Symbols show mean; error bars show SEM.
(C) EGFP-HCN1/DsRed2 ratio from slices infected with control siRNA divided
by ratio from slices infected with TRIP8b siRNA. Note selective decrease in
HCN1 staining in distal dendrites of SR and SLM. (Error bars, SEM). The
horizontal gray line indicates a ratio of 1.
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Targeting of HCN1 Channels by TRIP8b IsoformsKnockdown of TRIP8b Impairs the Expression
of EGFP-HCN1 in CA1 Distal Dendrites
To overcome some of the above limitations of immunohisto-
chemistry, we coinfected slices with viral vectors expressing
siRNA and EGFP-tagged HCN1 (EGFP-HCN1). To prevent inter-
ference from endogenous HCN1, we performed these experi-
ments in HCN1 knockout mice (Nolan et al., 2003; Santoro
et al., 2009). With the siRNA vector, a separate vector expressed
the soluble red fluorescent protein, DsRed2. We were therefore
able to examine channel distribution (green fluorescence) only
from those neurons coinfected with siRNA (red fluorescence).
Because we coinjected independent lentiviral vectors to coex-
press EGFP-HCN1 with siRNA, we could selectively monitor
the effect of TRIP8b knockdown on channels that were synthe-
sized de novo when endogenous levels of TRIP8b were being
reduced.
We previously found (Santoro et al., 2009) that virally ex-
pressed EGFP-HCN1 (in the background of the HCN1 KO
mouse) is properly trafficked to the distal apical dendrites of
CA1 pyramidal neurons in a gradient of increasing expression
that closely resembles the profile of endogenous HCN1 (Lorincz
et al., 2002; Notomi and Shigemoto, 2004; Santoro et al., 1997).
In contrast, DsRed2 is expressed uniformly throughout the
somatodendritic compartments (Figure 3A, center panels).
Although the dendritic targeting of EGFP-HCN1 was unaltered
by control siRNA, it was markedly perturbed by TRIP8b siRNA,
which greatly reduced EGFP fluorescence in distal CA1
dendrites with no detectable change in soma and proximal
dendrites (Figure 3A, left panels).
We analyzed the profile of channel expression by plotting the
ratio of EGFP-HCN1 to DsRed2 fluorescence as a function of
distance along the somatodendritic longitudinal axis (Figure 3B).
In slices that had been infected with control siRNA, this ratio was
relatively constant in the soma and proximal dendrites of SR
and increased steeply in the distal regions of SR into SLM,
reflecting the normal gradient of endogenous HCN1. TRIP8b
knockdown had little effect on the EGFP-HCN1 to DsRed2 fluo-
rescence ratio in the soma and proximal dendrites of SR.
However, there was a large decrease in the EGFP-HCN1 to
DsRed2 ratio in the distal regions of SR and throughout SLM.
A comparison of the ratio in slices expressing control siRNA to
the ratio in slices expressing TRIP8b siRNA confirmed that
downregulation of TRIP8b produced a selective reduction in
channel expression in CA1 distal dendrites (Figure 3C, N = 5
mice, 10 injection sites for TRIP8b siRNA and 4 mice, 8 injection
sites for control). This altered ratio was not caused by changes in
dendritic architecture as the DsRed2 distribution was unaffected
by the siRNA.
In summary, siRNA-mediated reduction of TRIP8b resulted in
a marked loss of HCN1 in the plasma membrane as detected by
several electrophysiological parameters that reflect Ih. Further-
more, knockdown of TRIP8b in vivo resulted in an increased
immunoreactivity for HCN1 channels in the CA1 soma and
proximal dendrites that represents a redistribution of HCN1
to intracellular compartments. Additionally, coexpression of
EGFP-HCN1 with TRIP8b siRNA revealed a selective loss of
channel fluorescence in SLM. All together, these results indicate
that, in addition to being important for HCN1 expression on theNeuron 70, 495–509, May 12, 2011 ª2011 Elsevier Inc. 499
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Figure 4. HCN1DSNL Truncation Mutant
Shows Defective Trafficking to CA1 Distal
Dendrites
(A and B) Images of CA1 region from hippocampal
slices from HCN1 KO mouse expressing EGFP-
HCN1 (A) or EGFP-HCN1DSNL (B). EGFP-tagged
channel fluorescence (left column) and as green
(right column). Staining for MAP2 dendritic marker
(middle column) and as red (right). Note that full-
length EGFP-HCN1 was trafficked efficiently to
distal apical dendrites whereas EGFP-HCN1DSNL
showed even dendritic distribution, with relatively
high expression in soma and proximal apical and
basal dendrites. The scale bar represents 200 mm.
(C) Higher magnification z-series projections
showing fluorescence signals for EGFP-HCN1,
EGFP-HCN1DSNL, and coexpressed DsRed2. The
scale bar represents 10 mm.
(D) EGFP and DsRed2 fluorescence intensities
were measured along somato-dendritic axis in
soma and apical dendrites of individual cells.
Mean EGFP signal averaged from individual
dendrites was normalized by DsRed2 signal and
plotted as function of distance from somatic layer
for neurons expressing EGFP-HCN1 (black) or
EGFP-HCN1DSNL (red). (Solid lines: means;
dashed lines: SEM).
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Targeting of HCN1 Channels by TRIP8b Isoformsplasmamembrane, TRIP8bmay also be important for the target-
ing of HCN1 to distal dendrites. However, the loss of HCN1 in
distal dendrites might not reflect a specific role of TRIP8b in
dendritic targeting but may be secondary to the general loss
of HCN1 surface expression upon TRIP8b knockdown. More-
over, because the TRIP8b siRNA reduced but did not eliminate
TRIP8b protein, it is unclear whether the residual targeting
of HCN1 to the distal dendrites results from an effect of
residual TRIP8b or represents the action of some other targeting500 Neuron 70, 495–509, May 12, 2011 ª2011 Elsevier Inc.protein that interacts with HCN1. To
address these questions, we adopted
a third, complementary approach, dis-
cussed next.
A C-Terminal EGFP-HCN1
Truncation Mutant with Impaired
Binding to TRIP8b Shows
Impaired Targeting to CA1 Distal
Dendrites
To overcome the limitations of the siRNA
approach, we expressed an EGFP-
tagged HCN1 truncation mutant (EGFP-
HCN1DSNL) that lacks the HCN1
C-terminal SNL tripeptide required for
high affinity binding of HCN1 to TRIP8b
(Santoro et al., 2004, 2011; Lewis et al.,
2009). We observed a dramatic loss of
dendritic targeting when we expressed
EGFP-HCN1DSNL in the background of
HCN1 KO mice (Figures 4A and 4B).
Unlike wild-type HCN1, the mutant
channel was expressed uniformly at highlevels throughout CA1, as evident in the relatively constant
EGFP-HCN1DSNL to DsRed2 fluorescence ratio along the soma-
todendritic axis. A comparison with the distribution of full-length
HCN1 revealed not only a loss of expression of the mutant
channel in the distal dendrites but also an increase in expression
in proximal dendrites (Figures 4C and 4D; EGF-HCN1: N = 4
mice, 8 injection sites; EGFP-HCN1DSNL: N = 5mice, 10 injection
sites). As TRIP8b is the major protein that interacts with the
HCN C terminus in the brain (Santoro et al., 2004, 2009; Zolles
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Figure 5. Whole-Cell Recordings from CA1 Neurons Expressing EGFP-HCN1 or EGFP-HCN1DSNL Indicate that the SNL Deletion Results in
a Mistargeting of HCN1
A series of electrophysiological properties were determined for CA1 pyramidal neurons fromHCN1KOmice expressing EGFP (control, black), EGFP-HCN1 (blue)
or EGFP-HCN1DSNL (red). (A) Somatic voltage traces from whole-cell current-clamp recordings showing expression of full-length or truncated HCN1 resulted in
a prominent depolarizing voltage sag in response to 100 pA hyperpolarizing current steps from a holding potential of 70 mV. (B) Expression of EGFP-HCN1
and EGFP-HCN1DSNL differentially enhanced t1/2 decay time of EPSPs in response to stimulation of proximal (SC) inputs (B1) versus distal (PP) inputs (B2). (B3)
Ratio of SC/PP EPSP t1/2 values was significantly different following expression of EGFP-HCN1 versus EGFP-HCN1DSNL. Peak amplitude input-output curves for
SC (C) and PP (D) EPSPs from CA1 pyramidal neurons expressing EGFP (black triangles), EGFP-HCN1 (blue circles) or EGFP-HCN1DSNL (red squares). (Error
bars: SEM).
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Targeting of HCN1 Channels by TRIP8b Isoformset al., 2009), these results strongly implicate TRIP8b as a key
element necessary for the efficient targeting of HCN1 channels
to distal portions of CA1 pyramidal neuron apical dendrites.
CA1 Neurons Expressing EGFP-HCN1DSNL Display
Altered Physiological Properties Consistent
with Channel Mistargeting
Because of the limitations of fluorescence imaging, we used an
electrophysiological approach to measure EGFP-HCN1DSNL
channel levels in the surface membrane in HCN1 KO mice. The
resting potential of neurons expressing EGFP-HCN1DSNL
(69.2 ± 1.2; n = 13) was identical to that of neurons expressing
EGFP-HCN1 (69.1 ± 1.1 mV; n = 15), and both were 14 mV
more positive than the resting potential of control neurons from
the HCN1 knockout mice expressing EGFP (82.7 ± 1.5 mV;
n = 15; p < 0.01 relative to full-length and mutant channels).
This suggests that the wild-type and mutant channels produced
similar increases in somatic Ih. Expression of full-length and
mutant channels also led to similar, significant decreases in input
resistance (EGFP- HCN1DSNL:107.2 ± 15.7 MU, n = 13; EGFP-
HCN1:109.1 ± 7 MU, n = 15) relative to that of control neuronsexpressing EGFP (149.6 ± 14 MU, n = 15; p < 0.01). Finally, sag
ratios were similarly enhanced (Figure 5A) in neurons
expressing EGFP-HCN1 (0.23 ± 0.03, n = 15) or EGFP-HCN1DSNL
(0.22 ± 0.02, n = 13), relative to that in control neurons from the
knockout mice (0.05 ± 0.01, n = 15; p < 0.01). Thus, expression
of EGFP-HCN1 and EGFP-HCN1DSNL in HCN1 KO mice yielded
large, nearly identical levels of Ih when measured at the soma.
Next, we assessed levels of Ih in CA1 proximal and distal
dendrites, based on the time course of decay of SC and PP
EPSPs (Figure 5B). In control knockout neurons expressing
EGFP, the t1/2 of the SC EPSP (35 ± 2ms) was significantly faster
than that of the PP EPSP (52 ± 4 ms; n = 15; p < 0.05), as
expected from the passive cable properties of the dendrite.
Expression of either EGFP-HCN1 or EGFP-HCN1DSNL led to
a speeding of the decay of the SC EPSP, although EGFP-
HCN1DSNL produced a significantly larger speeding of the t1/2
(23 ± 1 ms; n = 13) relative to the t1/2 with EGFP-HCN1 (27.7 ±
3 ms; n = 15; p < 0.05, compared with EGFP and EGFP-HCN1;
ANOVA, Tukey HSD). In contrast we observed the opposite
pattern for PP EPSPs; EGFP-HCN1 produced a significantly
larger speeding (t1/2 of 24 ± 2 ms; n = 15) compared with theNeuron 70, 495–509, May 12, 2011 ª2011 Elsevier Inc. 501
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Targeting of HCN1 Channels by TRIP8b Isoformstruncated channel (t1/2 of 29 ± 2 ms; n = 13; p < 0.05, ANOVA
Tukey HSD). The differential effect of full-length versus mutant
HCN1 on the decay of the PP versus SC EPSP was apparent
when we compared the ratio of SC EPSP to PP EPSP decay
times in neurons expressing EGFP, EGFP-HCN1 and EGFP-
HCN1DSNL (Figure 5B3). Whereas full-length HCN1 preferentially
sped the decay of the PP EPSP relative to the SC EPSP, the
mutant channel produced a similar speeding of EPSPs in both
pathways.
As a final assay of functional levels of Ih in dendritic compart-
ments, we compared the effects of the three different constructs
on the input-output curves for SC and PP EPSP peak amplitude,
as this parameter is reduced by high levels of HCN1 (George
et al., 2009; Magee, 1998). EGFP-HCN1 had no effect on the
input-output curve for SC EPSPs (Figures 5C and 5D), consistent
with the relatively low levels of full-length HCN1 in proximal
dendrites. In contrast, EGFP-HCN1DSNL decreased significantly
the SC EPSP amplitude, relative to the EPSP in either control
knockout neurons expressing EGFP or neurons expressing full-
length EGFP-HCN1 (p < 0.01, ANOVA with Tukey’s HSD test,
stimulus strengths >4 V) (Figure 5D). In contrast, EGFP-HCN1
caused a large reduction of the PP EPSP (p < 0.01, ANOVA
with Tukey’s HSD test relative to EGFP control EPSPs, stimulus
strengths >15 V) that was significantly greater than the reduction
seen with EGFP-HCN1DSNL (p < 0.05 ANOVA with Tukey’s HSD,
25 and 30 V stimulus strengths).
These results demonstrate that while full-length HCN1 is
targeted to CA1 distal dendrites, the truncation mutant is
expressed at high, relatively uniform levels in the somatoden-
dritic membrane throughout the CA1 neuron, consistent with
our results based on EGFP fluorescence. Thus, the loss of distal
dendritic targeting of HCN1DSNL is not secondary to loss of
membrane surface expression but must represent the loss of
a primary action of TRIP8b to target full-length HCN1 to distal
dendrites. As downregulation of TRIP8b with siRNA decreases
HCN1 surface expression, the HCN1DSNL results further indicate
that the actions of TRIP8b to enable proper surface membrane
expression and to direct distal dendritic targeting of HCN1 are
dissociable functions. This is consistent with recent reports
that HCN1 and TRIP8b interact at two distinct sites (Lewis
et al., 2009; Santoro et al., 2011) and that the weakened binding
between TRIP8b and HCN1DSNL is sufficient to allow certain
TRIP8b isoforms to enhance surface expression of the mutant
channel (see Discussion).
Which TRIP8b Splice Isoforms Are Important
for HCN1 Trafficking?
Although our results indicate that TRIP8b is critical for the proper
surface expression and dendritic targeting of HCN1 in CA1 pyra-
midal neurons, these data do not provide insight as to which
specific TRIP8b isoform (or combination of isoforms) is involved.
The identification of the role of individual isoforms is a daunting
task as there are at least ten different splice variants of TRIP8b
expressed in brain (Lewis et al., 2009; Santoro et al., 2009).
Moreover, the small size of the various alternatively spliced
exons makes it impractical to design selective siRNAs to knock-
down specific isoforms. Nonetheless, we obtained insight into
the function of specific isoforms by examining a mouse line,502 Neuron 70, 495–509, May 12, 2011 ª2011 Elsevier Inc.Pex5ltm1(KOMP)Vlcg, in which exons 1b and 2 in the TRIP8b gene
were replaced by lacZ through homologous recombination
(http://www.komp.org; Figure S2). The removal of all splice
forms containing exons 1b or 2 is expected to delete all except
three of the TRIP8b splice isoforms, namely TRIP8b(1a),
TRIP8b(1a-4) and TRIP8b(1a-3-4). Of these, TRIP8b(1a) and
TRIP8b(1a-4) are the most abundant splice forms in the mouse
brain, accounting for 25%–30% and 30%–40%, respectively,
of total TRIP8b mRNA. In contrast, TRIP8b(1a-3-4) is normally
expressed at very low levels in brain (<5% of total brain TRIP8b
mRNA; (Santoro et al., 2009) and is not detected in hippocampus
(Lewis et al., 2009).
The TRIP8b exon 1b/2 KO mice are generally viable, with
normal body weight and overall brain structure. Western blot
analysis of brain extracts from these mice confirmed the loss
of all TRIP8b isoforms containing exons 1b or 2. In contrast,
the hippocampal TRIP8b isoforms lacking these exons,
TRIP8b(1a) and TRIP8b(1a-4), showed strong signals onwestern
blots of brain extracts from the knockout mice, although the
levels of expression of these isoforms were reduced somewhat
compared with those seen in wild-type littermates (Figure S2).
Moreover, the remaining TRIP8b splice forms showed a normal
dendritic pattern of immunohistochemical staining in the CA1
region of the KO mice (Figure 6A; see also Figures S3 and S4).
Remarkably, despite the loss of all but two of the hippocampal
TRIP8b isoforms, the endogenous expression pattern of HCN1
in the CA1 region of the KO mice was identical to that of wild-
type mice, with the characteristic dendritic gradient of HCN1
expression (Figures 6C and 6D; see also Figure S4). Combined
with our above results using siRNA and EGFP-HCN1DSNL, which
demonstrated the general importance of TRIP8b isoforms for
HCN1 expression and dendritic targeting, the results from the
1b/2 KO mice indicate that TRIP8b(1a-4) and/or TRIP8b(1a)
must be the key isoforms that regulate HCN1 trafficking in CA1
neurons.
What is the role of the TRIP8b isoforms containing exons 1b or
2? Although the endogenous staining pattern with the pan-
TRIP8b antibody in CA1 was very similar in the knockout and
control animals, labeling disappeared in the KO mice from
a distinct population of small cells enriched in the dentate gyrus
and CA3 regions (Figure 6B). These cells, present throughout the
brain, are likely oligodendrocytes, as theywere colabeledwith an
antibody to 20, 30-cyclic nucleotide 30-phosphodiesterase
(CNPase), an oligodendrocyte-specific marker (Figure S3).
Furthermore, we detected b-galactosidase (which replaced
exons 1b/2 in the KO mice, see Figure S2) in these cells of the
1b/2 KO animals, indicating that these cells normally express
exons 1b and 2 (Figure S3). Although oligodendrocytes do not
express HCN1, they do express HCN2 (Notomi and Shigemoto,
2004), which also interacts strongly with TRIP8b (Santoro et al.,
2004; Zolles et al., 2009).
TRIP8b(1a-4) and TRIP8b(1a) Are Expressed in CA1
Neuron Axonal-Dendritic Compartments
To elucidate further the potential role of TRIP8b(1a) and
TRIP8b(1a-4) in the trafficking of HCN1 in the hippocampus,
we examined their endogenous localization in wild-type and
KO mice using exon-specific antibodies. We first studied
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Figure 6. Expression of TRIP8b and HCN1 in
Hippocampal Slices from TRIP8b Exon 1b/2
Knockout Mice
(A) Coronal hippocampal sections from wild-type and
TRIP8b exon 1b/2 knockout mice littermates. Slices were
labeled with amonoclonal pan-TRIP8b antibody that binds
to all isoforms. The scale bar represents 500 mm.
(B) Higher magnification z-axis projection of area CA3 from
wild-type and TRIP8b 1b/2 KO mice, showing loss of pan-
TRIP8b staining from small glial-like cells following dele-
tion of exons 1b and 2. The scale bar represents 100 mm.
(C) Immunolabelling of slices from wild-type and TRIP8b
1b/2 KO littermates mice showing a normal expression
pattern of endogenous HCN1 throughout the hippo-
campus. The scale bar represents 500 mm.
(D) Higher magnification z-axis projection of area CA1
showing the identical targeting of HCN1 to distal dendrites
in SLM of wild-type and TRIP8b 1b/2 KO mice. The scale
bar represents 100 mm.
Neuron
Targeting of HCN1 Channels by TRIP8b Isoformsimmunohistochemical staining with a mouse monoclonal anti-
body that specifically recognizes exon 4. In hippocampal
slices from wild-type mice, exon 4 labeling was detected
in a pattern very similar to that of endogenous HCN1. Thus,
labeling was present at highest levels in the SLMof CA1 and sub-
iculum, with a sharp cutoff in signal at the CA1-CA2 border
(Figures 7A and 7B). Although four TRIP8b splice isoforms that
containexon4 (TRIP8b(1a-2-3-4), TRIP8b(1a-2-4), TRIP8b(1a-4),
and TRIP8b(1b-2-4)) are normally expressed in hippocampus
(Santoro et al., 2009), TRIP8b(1a-4) is by far the most abundant
(Santoro et al., 2009). Moreover, we found that the hippocampalNeuron 70staining pattern for exon 4 was identical in wild-
type and 1b/2 knockout mice (Figure S4). Thus,
the exon 4 antibody signal in wild-type animals
is likely to predominantly represent staining for
TRIP8b(1a-4), as all other exon 4-containing
isoforms normally expressed in hippocampus
were deleted in the knockout mice. These
immuno-histochemistry data, together with
previous findings that TRIP8b(1a-4) promotes
HCN1 surface expression in heterologous cells
(Lewis et al., 2009; Santoro et al., 2009), suggest
that TRIP8b(1a-4) is likely to be a key TRIP8b iso-
form that promotes the surface expression and
efficient targeting of HCN1 to the CA1 distal
dendrites.
Next we examined the expression pattern of
TRIP8b(1a) using a chicken polyclonal antibody
recognizing a peptide corresponding to the
junction of exons 1a and 5. This antibody prefer-
entially detected TRIP8b(1a) over TRIP8b(1a-4),
based on western blot analysis, and detected
virally expressed TRIP8b(1a) in CA1 neurons
by immunohistochemistry (Figure S5). The stain-
ing pattern with the TRIP8b(1a) antibody was
distinct and remarkably complementary to
both the staining with the exon 4 antibody and
the staining pattern of HCN1. Thus, in the hippo-campus, TRIP8b(1a) was detected at highest levels in the alveus,
where TRIP8b(1a-4) and HCN1 staining were lacking. Although
the TRIP8b(1a) antibody did stain the SLM of CA1 and subiculum
(Figure 7C), high magnification z-axis projections revealed that
the TRIP8b(1a) signal was present in dense bundles of fibers
running semiperpendicularly to the dendritic axis of the CA1
pyramidal neurons (Figure 7D). This is distinct from the diffuse
SLM signal seen with the antibody against exon 4. Sparse fibers
were also detected with the TRIP8b(1a) antibody in SR and SO.
TRIP8b(1a)-labeled fibers were colabeled with an antibody to
intermediate-sized neurofilament, an axonal marker (Figure S6)., 495–509, May 12, 2011 ª2011 Elsevier Inc. 503
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Figure 7. The Endogenous Expression Patterns of
TRIP8b Isoforms Containing Exon 4 and TRIP8b(1a)
Show Complementary Localization
(A) Coronal brain sections immunolabeled with an antibody
specific to exon 4 of TRIP8b. Strongest signal was seen in
distal dendrites of CA1 in SLM. The scale bar represents
500 mm.
(B) Higher-magnification z-projection image of CA1
neurons immunolabeled with antibody to TRIP8b exon 4.
The scale bar represents 100 mm.
(C) Immunolabeling with an antibody recognizing
TRIP8b(1a). Note the high expression in the alveus of the
hippocampus. The scale bar represents 500 mm.
(D) Higher magnification images reveal that TRIP8b(1a) is
localized to fiber bundles in SO, SLM and in sparse fibers in
SR. The scale bar represents 100 mm.
Neuron
Targeting of HCN1 Channels by TRIP8b IsoformsThese results suggest that TRIP8b(1a) is present in axonal fibers,
including those of CA1 pyramidal cells, which project through the
alveus. Of interest, little or no staining for endogenous HCN1was
detected in such fibers, as seen by comparing Figure 6D with
Figure 7D. Given that TRIP8b(1a) downregulates HCN1 surface
expression in Xenopus oocytes (Santoro et al., 2009), our find-
ings suggest that TRIP8b(1a) may act to suppress HCN1 channel
misexpression in CA1 neuron axons.
Effects of Overexpression of HA-Tagged TRIP8b(1a-4)
and TRIP8b(1a) on EGFP-HCN1 Trafficking in Dendrites
of CA1 Pyramidal Neurons
To test the hypothesis that TRIP8b(1a-4) enhancesHCN1 surface
expression and targets the channel to its proper dendritic locale
whereas TRIP8b(1a) prevents axonal expression of the channel,
we examined the effects of viral overexpression of these two
TRIP8b isoforms, both fused toanHA tag toallowus todistinguish
exogenous fromendogenousprotein. Inapreviousstudy (Santoro
et al., 2009), coexpression of TRIP8b(1a-4)-HA with EGFP-HCN1
enhanced expression of the channel in the surface membrane of
CA1 neuron apical dendrites. However, the normal targeting of
the channel to the distal dendrites was perturbed as HCN1 was
present uniformly throughout the somatodendritic axis.
In our present experiments, we confirmed that overexpression
of TRIP8b(1a-4)-HA enhanced expression and caused mislocal-
ization of EGFP-HCN1 as previously described (Figure 8A, right;504 Neuron 70, 495–509, May 12, 2011 ª2011 Elsevier Inc.compare to Figure 4A). In addition, by staining
for the HA tag, we found that overexpressed
TRIP8b(1a-4)-HA was present in a uniform
dendritic distribution similar to that of EGFP-
HCN1 (Figure 8A, left), in contrast to the distal
dendritic localization of endogenous
TRIP8b(1a-4) (see Figure 7A). Although overex-
pressedTRIP8b(1a-4)-HA fails to formadendritic
gradient, the fact that HCN1 is consistently colo-
calized with TRIP8b(1a-4), either under physio-
logical conditions when both are targeted to
distal dendrites or when TRIP8b(1a-4)-HA is
overexpressed and both are present in a uniform
distribution, suggests that TRIP8b(1a-4) is a key
isoform that helps direct channel localization.The above hypothesis is supported by the contrasting action
of overexpressed TRIP8b(1a)-HA. When coexpressed with
EGFP-HCN1, TRIP8b(1a)-HA was detected in an even distribu-
tion throughout CA1 pyramidal neurons (Figure 8B, left),
similar to the localization of TRIP8b(1a-4)-HA. However, unlike
with TRIP8b(1a-4)-HA, the dendritic expression of EGFP-HCN1
was unaltered by TRIP8b(1a)-HA, with the channel displaying a
normal localization in CA1 distal dendrites (Figure 8B, right).
The lack of change in EGFP-HCN1 dendritic targeting is consis-
tent with the view that TRIP8b(1a)may act preferentially in axons.
Effects of Overexpression of HA-Tagged TRIP8b(1a-4)
and TRIP8b(1a) on EGFP-HCN1 Trafficking in Axons
of CA1 Pyramidal Neurons
To test directly the idea that TRIP8b(1a) prevents HCN1 misloc-
alization in CA1 pyramidal neuron axons, we examined the
effects of overexpressing HA-tagged TRIP8b(1a) on axonal
EGFP-HCN1. Although endogenous levels of HCN1 in CA1 pyra-
midal neuron axons are normally very low (see Lorincz et al.,
2002; Notomi and Shigemoto, 2004), a strong fluorescence
signal for overexpressed EGFP-HCN1 was observed in CA1
axonal fibers running through SO and alveus of the hippocampus
(Figures 9A–9C). Perhaps the clearest evidence that EGFP-
HCN1 was present in CA1 axons comes from our finding of
a strong fluorescence signal in SO of CA1 and subiculum in the
hemisphere contralateral to that where virus was injected
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(A) CA1 region of hippocampus of HCN1 knockout mouse
infected with independent viruses expressing HA-tagged
TRIP8b(1a-4) and EGFP-HCN1. Left column. Immunoflu-
orescence from anti-HA antibody, reflecting location of
expressed TRIP8b(1a-4). Right column, EGFP-HCN1
fluorescence. Note how EGFP-HCN1 expression pattern
mirrored that of TRIP8b(1a-4)-HA.
(B) Localization of virally expressed HA-tagged TRIP8b(1a)
and coexpressed EGFP-HCN1.
(C) Localization of mutant TRIP8b(1a)LL/AA-HA and coex-
pressed EGFP-HCN1. The scale bars represent 100 mm.
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Targeting of HCN1 Channels by TRIP8b Isoforms(Figures 9A and 9B), sites where commissural CA1 axons are
known to project (van Groen and Wyss, 1990).
Strikingly, coexpression of TRIP8b(1a)-HA with EGFP-HCN1
eliminated channel fluorescence in axon fibers in both contralat-
eral (Figure 9F) and ipsilateral hippocampus (Figure 8B). This
effect represents a local action to downregulate channel expres-
sion in axons because TRIP8b(1a)-HA caused no change in the
dendritic expression of HCN1 (Figure 8B). Moreover the effect
is isoform-specific as TRIP8b(1a-4)-HA had no effect on axonal
expression of EGFP-HCN1 (Figure 9E). Further confirmation of
the specificity of action of TRIP8b(1a) comes from our finding
that TRIP8b(1a)-HA caused no change in the dendritic or axonal
expression of EGFP-HCN1DSNL (Figure S7), whose membrane
expression also cannot be downregulated by TRIP8b(1a) in
Xenopus oocytes (Santoro et al., 2011; see Discussion).Neuron 70Downregulation of HCN1 surface expression
by TRIP8b(1a) in Xenopus oocytes is dependent
on the presence of a dileucine adaptor protein
trafficking motif in the control of axonal expres-
sion of HCN1 (Bonifacino and Traub, 2003) in
the N-terminal domain of the TRIP8b protein
(Santoroet al., 2009). Toexamine the importance
of this motif we coexpressed EGFP-HCN1 with
TRIP8b(1a)LL/AA-HA, whose dileucine residues
were substituted with alanine (L18A/L19A, see
Santoro et al., 2009). Unlike the wild-type
protein, TRIP8b(1a)LL/AA-HA failed to prevent
the mislocalization of EGFP-HCN1 in axons in
both contralateral (Figure 9G) and ipsilateral
hippocampus (Figure 8C), even though the
mutant protein was expressed at high levels.
These results strongly support the view that
TRIP8b(1a) exerts a highly specific action to
prevent HCN1 mislocalization in axons through
adirect interactionwith thechannel and the likely
recruitment of adaptor protein complexes.
DISCUSSION
Our results demonstrate that TRIP8b splice iso-
forms are necessary for the proper trafficking of
HCN1 channels to the surface membrane of
CA1 pyramidal neurons and for the proper tar-geting of the channels to the distal dendritic compartment.
Furthermore, of the more than ten TRIP8b isoforms present in
brain, TRIP8b(1a) and TRIP8b(1a-4) appear to bemost important
for proper HCN1 localization in hippocampal CA1 pyramidal
neurons. In particular, we suggest that TRIP8b(1a) largely
prevents HCN1 misexpression in axons whereas TRIP8b(1a-4)
enhances channel surface expression and ensures proper
dendritic targeting.
Effect of General Knockdown of HCN1 Interaction
with All TRIPb Isoforms
Lewis et al. (2009) previously reported that the reduction of
all TRIP8b isoforms with siRNA suppresses HCN1 membrane
expression and Ih in hippocampal neurons in dissociated cell
culture. In addition to confirming these in vitro results, we, 495–509, May 12, 2011 ª2011 Elsevier Inc. 505
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Figure 9. TRIP8b(1a) Downregulates Expression of
EGFP-HCN1 in Axons
(A) Low magnification image of EGFP-HCN1 fluorescence
from hippocampus of HCN1 KO mouse infected with
independent TRIP8b(1a)-HA and EGFP-HCN1 viral
vectors.
(B) Fluorescence image from uninjected contralateral
hippocampus from samemouse. The scale bars represent
500 mm.
(C) Diagram illustrating the distal dendritic expression
pattern of infected neurons at injection site and the loca-
tion of axonal fibers in the contralateral hippocampus. The
blue, green and red boxes correspond to the regions
shown in (A), (B), and (D).
(D) Higher-magnification image of EGFP-HCN1 labeled
axonal fibers in the contralateral hippocampus. The scale
bar represents 20 mm.
(E–G) Similar experiment as in (A)–(D), except EGFP-HCN1
is coexpressed with TRIP8b(1a-4)-HA (E), TRIP8b(1a)-HA
(F), or TRIP8b(1a)LL/AA (G). Note how TRIP8b(1a)-HA
selectively downregulates EGFP-HCN1 in axons. The
scale bar represents 20 mm.
Neuron
Targeting of HCN1 Channels by TRIP8b Isoformsfound that downregulation of TRIP8b in vivo inhibited HCN1
membrane expression and Ih in CA1 neurons. In particular,
we observed a marked decrease in HCN1 expression in CA1
distal dendrites. Our results with in vivo siRNA knockdown
thus provide clear evidence that TRIP8b is necessary for the
proper expression and localization of HCN1 in CA1 neuronal
compartments.
This conclusion is supported by our finding that an HCN1 trun-
cation mutant lacking its C-terminal TRIP8b interaction peptide,
HCN1DSNL, which has a decreased affinity for TRIP8b, failed to
localize to the CA1 distal dendrites. As the mutant channel was
strongly expressed in the surface membrane throughout the so-
matodendritic compartment in a fairly uniform manner, we
further conclude that HCN1 surface expression and dendritic
targeting are dissociable functions of TRIP8b that are differen-
tially sensitive to alterations in its biochemical interactions with
HCN1 (see below).506 Neuron 70, 495–509, May 12, 2011 ª2011 Elsevier Inc.Role of Different TRIP8b Isoforms
in Regulating HCN1 Expression
and Dendritic Localization
The task of defining the importance of individual
TRIP8b splice forms in the surface expression
and targeting of HCN1 to its proper neuronal
compartments was greatly simplified by the
availability of a mouse line, Pex5ltm1(KOMP)Vlcg,
in which TRIP8b exons 1b and 2 were selec-
tively deleted by homologous recombination.
Remarkably, despite the loss of all but three of
the more than ten TRIP8b splice forms normally
present in the brain, the dendritic staining
pattern of HCN1 was unaltered in CA1 neurons
in the mutant mice. A comparison of TRIP8b
expression in wild-type and KO mice further
revealed that TRIP8b isoforms containing
exons1b or 2 are normally present predomi-
nantly in small CNPase-positive oligodendro-cytes. The functional role of TRIP8b in these cells, and whether
this role depends on an interaction with HCN2 channels present
in oligodendrocytes, is unknown (Notomi and Shigemoto, 2004).
The data with the TRIP8b 1b/2 knockout mice strongly
suggest that TRIP8b(1a-4) is a key isoform important in the
establishment of the HCN1 dendritic gradient in CA1 pyramidal
neurons. Thus, of TRIP8b(1a), TRIP8(1a-4), and TRIP8b(1a-3-4),
the three isoforms expressed in the knockout mice, TRIP8b(1a-
3-4) is unlikely to be important as it is present at very low levels in
brain (Santoro et al., 2009) and is not detected in hippocampus
(Lewis et al., 2009). Because HCN1 dendritic targeting was
unperturbed in the KOmouse but was disrupted when all TRIP8b
isoforms were downregulated with siRNA (or when their interac-
tion with HCN1 was inhibited in the HCN1DSNL mutant), we
conclude that either TRIP8b(1a-4) or TRIP8b(1a) must be neces-
sary and sufficient for HCN1 to be properly localized to CA1
distal dendrites. Furthermore, as TRIP8b(1a) immunostaining
Neuron
Targeting of HCN1 Channels by TRIP8b Isoformswas largely limited to axons, TRIP8b(1a-4) appears the most
likely isoform required for dendritic targeting of HCN1. This
view is supported by our finding that TRIP8b(1a-4) was concen-
trated and colocalized with HCN1 in the distal dendrites of CA1
neurons, in both wild-type and TRIP8b 1b/2 KO mice, and by
previous results that overexpression of TRIP8b(1a-4) markedly
enhances the surface expression of HCN1 in heterologous cells
and CA1 pyramidal neurons (Santoro et al., 2009).
At first glance, our observation that HCN1DSNL, which has
a reduced binding affinity for all TRIP8b isoforms, was strongly
expressed in the surface membrane of CA1 neurons seems at
oddswith the siRNA findings that TRIP8b in general was required
for efficient trafficking of HCN1 to the surface membrane.
However, TRIP8b and HCN1 have been recently found to
interact at two distinct sites, only one of which involves the
SNL sequence (Lewis et al., 2009; Santoro et al., 2011). In addi-
tion, our laboratory recently reported that TRIP8b(1a-4) retains
its full functional ability to upregulate surface expression of the
HCN1DSNL mutant channel when heterologously expressed in
Xenopus oocytes. Thus, the residual interaction of TRIP8b(1a-4)
with the mutant HCN1 channel is likely to account for its strong
surface expression.
The ability of TRIP8b(1a-4) to upregulate surface membrane
expression of HCN1DSNL raises the question as to why this inter-
action failed to localize properly the mutant channel to the CA1
distal dendrites. One explanation is that dendritic targeting and
channel surface expression depend on distinct interactions of
HCN1 with TRIP8b(1a-4) that are differentially sensitive to the
loss of the SNL binding site. Alternatively, proper dendritic local-
ization may require the cooperative interaction of TRIP8b(1a-4)
with TRIP8b(1a), whose action to downregulate HCN1 surface
expression in heterologous expression systems is eliminated
upon deletion of the SNL tripeptide (Santoro et al., 2011).
A second result seemingly at odds with the hypothesis that
TRIP8b(1a-4) specifies the dendritic gradient of HCN1 is that
exogenously expressed TRIP8b(1a-4)-HA did not localize to
distal CA1 dendrites but showed a relatively uniform expression
throughout the somatodendritic compartment. We suggest that
TRIP8b(1a-4) must interact with a separate trafficking element,
possibly another protein or mRNA targeting motif, that is in
limited supply. As a result, there may have been an insufficient
amount of this factor to ensure proper dendritic targeting of
TRIP8b(1a-4)-HA when it was overexpressed. Nonetheless, our
finding that HCN1 expression matches that of TRIP8b(1a-4),
both under physiological conditions when the two proteins are
present in a dendritic gradient and during overexpression
when both proteins are present in a uniform distribution, implies
that the high concentration of endogenous TRIP8b(1a-4) in the
distal dendrites of CA1 neurons should be sufficient to localize
HCN1 channels at this site under physiological conditions.
Comparison of HCN1 Dendritic Targeting with Polarized
Trafficking of Other Ion Channels
It is of interest to consider our findings on the role of TRIP8b iso-
forms in the trafficking of HCN1 in the context of previous results
on the trafficking of other neuronal membrane proteins to
different polarized neuronal compartments. Four distinct mech-
anisms have been reported (Arnold, 2009): (1) Some proteins arepresent in transport vesicles that are directly targeted to the
proper compartment. (2) Other proteins are shipped indiscrimin-
ately to all neuronal compartments, but then removed by endo-
cytosis from inappropriate regions. (3) Still other proteins are
also transported indiscriminately, but the transport vesicles
only dock in the appropriate compartment. (4) Finally some
proteins are targeted through transcytosis, in which the protein
is first expressed in one compartment from which it is removed
by endocytosis and then shipped to the appropriate locale
through recycling endosomes (Lasiecka et al., 2009).
With respect to these four mechanisms, perhaps the simplest
view is that TRIP8b(1a-4) promotes HCN1 distal dendritic
targeting through mechanism 1 whereas TRIP8b(1a) prevents
axonal mislocalization through mechanism 2. However, the two
isoformsmight also act sequentially through transcytosis (mech-
anism 4). This latter mechanism could explain why HCN1DSNL,
whose SNL truncation prevents its downregulation by
TRIP8b(1a), fails to be targeted to the distal dendrites despite
its continued interaction with TRIP8b(1a-4) that enhances
channel surface expression. Exploration of these possibilities
will provide an ample challenge for future work.
Functional Role and Dynamic Regulation of Dendritic
HCN1 Channels in Hippocampal Pyramidal Neurons
By comparing the electrophysiological properties of CA1
neurons from HCN1 knockout mice that have been rescued
with either full-length EGFP-HCN1 or EGFP-HCN1DSNL, our
experiments reveal how the proper targeting of HCN1 to its
dendritic locale is required for the normal processing of informa-
tion through the hippocampal circuit by CA1 neuron dendrites.
Thus, we found that the preferential targeting of full-length
HCN1 to the distal dendrites is required for the selective inhibi-
tory action of this channel on the integration of distal PP EPSPs
relative to more proximal SC EPSPs (Nolan et al., 2004). This
selective effect helps ensure that the distal PP EPSPs will have
a relatively weak influence at the CA1 neuron soma, relative to
the proximal SC EPSPs. In contrast, we found that themistarget-
ing of EGFP-HCN1DSNL to proximal dendrites changes the
normal balance of the two inputs, enhancing the contribution
of the PP EPSPs while decreasing the contribution of the SC
EPSPs.
The marked effects that the various TRIP8b isoforms exert on
HCN1 surface levels also provide a potential molecular mecha-
nism to explain the recent findings that the levels of Ih in neurons
are not fixed but can be increased or decreased by different
patterns of neural activity that induce synaptic plasticity (Brager
and Johnston, 2007; Campanac et al., 2008; Fan et al., 2005).
Alterations in TRIP8b-HCN1 interactions may also contribute to
the maladaptive changes in HCN1 expression associated with
seizures that is thought to contribute to the development of
epilepsy (Brewster et al., 2002, 2005; Chen et al., 2001; Jung
et al., 2007; Shah et al., 2004; Shin and Chetkovich, 2007), an
effect that is, in part, due to a redistribution of HCN1 from the
distal dendrites to the soma of CA1 neurons (Shin et al., 2008).
Given the strong regulatory action of TRIP8b splice variants on
the surface expression and compartmentalization of both native
and exogenous HCN1 in vivo, it will be of interest to determine
how changes in expression of specific TRIP8b isoforms playsNeuron 70, 495–509, May 12, 2011 ª2011 Elsevier Inc. 507
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studies examining the regulation of TRIP8b alternative splicing
and posttranslational modifications by signaling cascades may
further enhance our understanding of how this auxiliary subunit
acts as a central regulator of Ih, thereby influencing the excit-
ability and plasticity of the hippocampal circuit.
EXPERIMENTAL PROCEDURES
Lentivirus Expression
The lentiviral expression vector containing the CaMKII promoter, pFCK(0.4)
GW was provided by Pavel Osten (Max Planck Institute, Heidelberg) (Dittgen
et al., 2004). Subcloning and virus preparation were carried out essentially
as described (Santoro et al., 2009; see also Supplemental Experimental Proce-
dures). For in vivo delivery, virus was concentrated to 108 IU/ml in sterile saline
and stereotaxically injected into the hippocampal CA1 region of adult mice
(aged 3–9 months). HCN1 knockout animals (genotype HCN1/) were gener-
ated and bred as described (Nolan et al., 2003). For all siRNA and EGFP-
HCN1DSNL experiments, at least four animals were bilaterally injected for
each experimental condition, with eight to ten injection sites analyzed. For
all experiments investigating the interaction between EGFP-HCN1 and
TRIP8b(1a-4) or TRIP8b(1a-4)-HA, 8 mice were unilaterally injected for each
experimental condition, with eight injection sites analyzed.
Immunohistochemistry
Animals were perfused with ice-cold 13 PBS followed by 4% paraformalde-
hyde in 13 PBS; 50 mm slices were cut with a vibratome, and permeabilized
in PBS+0.2% Triton, followed by incubation in blocking solution (PBS+0.2%
Triton+3%normal goat serum). For stainingwith theTRIP8b(1a) antibody, anti-
body retrieval was performed by incubating slices for 30 min in 10 mM sodium
citrate at 80C before blocking. Primary antibody incubation was carried out in
blocking solution overnight at 4C. For a complete list of antibodies used see
Supplemental Experimental Procedures. Slices were mounted with Immuno-
gold (Invitrogen), and fluorescence imaging performed on inverted laser scan-
ning confocal microscopes (BioRad MRC 1000, Olympus FV1000, Zeiss LSM
700). For immunohistochemistry with Pex5ltm1(KOMP)Vlcg animals, two aged-
matchedpairs of Trip8b1b/2 andcontrol littermateswere examined.All images
were analyzed with ImageJ (NIH) and IGORPro software (Wavemetrics).
siRNA Knockdown
siRNA target sequences were selected using the GenScript and Ambion algo-
rithms, and dsDNA oligonucleotides cloned into the pLLhS lentivirus vector
(Nakagawa et al., 2004) under control of the U6 promoter. The pLLhS vector
also expressed EGFP under the control of the synapsin promoter. siRNA effi-
cacy was assayed by western blot analysis from cultured neuronal extracts;
one TRIP8b siRNA construct greatly reduced the levels of TRIP8b protein (Fig-
ure 1) compared with control siRNA. This TRIP8b- siRNA targeted nucleotide
positions 1419–1439 in the TRIP8b(1b-2) isoform cDNA sequence (50-CCA
CCTGAGTGGAGAGTTCAA-30) in constant exon 14 (Santoro et al., 2009).
The control siRNA construct was similarly constructed, but encodes a scram-
bled target sequence. Histology and electrophysiology were performed two to
3 weeks after viral injection.
TRIP8b Exon 1b/2 Knockout Mouse
The Trip8b exon1b and 2 knockout mice were generated by the NIH KOMP
mutagenesis project. Details of the mouse can be found at www.komp.org.
In summary, Regeneron designed the targeting vector (project ID VG11153)
used to generate the allele Pex5ltm1(KOMP)Vlcg. The lacZ coding sequence
was inserted directly after the start codon in exon 1b, followed by a neomycin
selection cassette flanked by loxP sites, replacing all of exons 1b and 2 (see
Figure S3). Note that despite the presence of polyadenylation sites both
following the lacZ as well as the neomycin coding sequences in the targeting
cassette, alternate start sites still enabled translation of TRIP8b splice isoforms
starting with exon 1a (see Figure 6A and Figure S2). The occurrence of read-
through transcripts from exon 1a through the constant region of TRIP8b was
verified through RT-PCR (data not shown).508 Neuron 70, 495–509, May 12, 2011 ª2011 Elsevier Inc.Acute Hippocampal Slices and Electrophysiology
Lentivirus was stereotactically injected into the dorsal hippocampi of 5-week-
old mice. Transverse hippocampal slices (400 mm) were prepared two weeks
after viral injection. Animals were sacrificed in accordance to institutional
IACUC standards. For solution composition and detailedmethods see Supple-
mental Experimental Procedures. Virally infected neurons were identified by
EGFP fluorescence. Following recordings of infected neurons, slices were
fixed for 30 min in PFA and imaged to ensure that all dye-filled cells were
also EGFP+ and that the dendritic structure of infected cells was normal.
Series resistance was less than 15 MU; capacitance and series resistance
were monitored and compensated throughout the experiments. Recordings
were performed at 32C. All datawas aquiredwith Pclamp software (Molecular
Devices) and analyzed with IGORPro (wavemetrics).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at doi:10.1016/
j.neuron.2011.03.023.ACKNOWLEDGMENTS
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